BN Business News
Add your company to Business Communicator →

Regulation & law · 16/11/2004Updated: 10/17/2026 · 1 min read

DEA Withdraws Misleading FAQ on Controlled Substances for Pain Treatment

The US Drug Enforcement Administration (DEA) has withdrawn a 2004 FAQ document due to misstatements, and is set to address the issue of dispensing controlled substances for pain treatment in a future Federal Register document.

Original source language: Federal Register — Justice DepartmentOpen original release →

Explore insights

Business insights →